Tag : Keymed Biosciences

Clinical Research, Pharma & Healthcare Financing

Keymed Biosciences Reports 2025 Annual Results & Updates

PR Newswire
by PR Newswire030
Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. Total revenue in 2025 was approximately RMB 720 million, a 67% year-on-year increase. This included around...